Other Species / Isoforms
  PPP1R2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K12
TASHRPIKGILKNKT
0 1
PPP1R2 (human) TASHRPIKGILKNKT K12
PPP1R2 (mouse) TASHRPIKGILKNKT K12
PPP1R2 (rat) TASHRPIkGILKNKT K12-ac
PPP1R2 (rabbit) TASHRPIKGILKNKT K12
S20-p
GILKNKTsTTssMVA
0 8
PPP1R2 (human) GILKNKTsTTssMVA S20-p
PPP1R2 (mouse) GILKNKTsAAsPPVV S20-p
PPP1R2 (rat) GILKNKTSTTSSVVA S20
PPP1R2 (rabbit) GILKNKTSSTSSRVA S20
S23-p
KNKTsTTssMVAsAE
0 11
PPP1R2 (human) KNKTsTTssMVAsAE S23-p
PPP1R2 (mouse) KNKTsAAsPPVVPSA S23-p
PPP1R2 (rat) KNKTSTTSSVVASAE S23
PPP1R2 (rabbit) KNKTSSTSSRVASAE S23
S24-p
NKTsTTssMVAsAEQ
0 2
PPP1R2 (human) NKTsTTssMVAsAEQ S24-p
PPP1R2 (mouse) KTsAAsPPVVPSAEQ P25
PPP1R2 (rat) NKTSTTSSVVASAEQ S24
PPP1R2 (rabbit) NKTSSTSSRVASAEQ S24
S28-p
TTssMVAsAEQPrGN
0 2
PPP1R2 (human) TTssMVAsAEQPrGN S28-p
PPP1R2 (mouse) AsPPVVPSAEQPRPI S29
PPP1R2 (rat) TTSSVVASAEQPRRT S28
PPP1R2 (rabbit) STSSRVASAEQPRGS S28
R33-m1
VAsAEQPrGNVDEEL
0 1
PPP1R2 (human) VAsAEQPrGNVDEEL R33-m1
PPP1R2 (mouse) VPSAEQPRPIVEEEL R34
PPP1R2 (rat) VASAEQPRRTVEEEL R33
PPP1R2 (rabbit) VASAEQPRGSVDEEL R33
S44-p
DEELSKKsQKWDEMN
Upstream
Downstream
2 0
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • ATM (human)
Putative in vivo kinases:
  • ATM (human)
Treatment
  • ionizing_radiation
PPP1R2 (human) DEELSKKsQKWDEMN S44-p
PPP1R2 (mouse) EEELSKKSQKWDEMN S45
PPP1R2 (rat) EEELSKKsQKWDEMN S44-p
PPP1R2 (rabbit) DEELSKKSQKWDEMN S44
T55-p
DEMNILAtyHPADKD
0 1
PPP1R2 (human) DEMNILAtyHPADKD T55-p
PPP1R2 (mouse) DEMNILATYHPADKD T56
PPP1R2 (rat) DEMNILATYHPADKD T55
PPP1R2 (rabbit) DEMNILATYHPADKD T55
Y56-p
EMNILAtyHPADKDy
0 8
PPP1R2 (human) EMNILAtyHPADKDy Y56-p
PPP1R2 (mouse) EMNILATYHPADKDy Y57
PPP1R2 (rat) EMNILATYHPADKDY Y56
PPP1R2 (rabbit) EMNILATYHPADKDY Y56
Y63-p
yHPADKDyGLMKIDE
0 30
PPP1R2 (human) yHPADKDyGLMKIDE Y63-p
PPP1R2 (mouse) YHPADKDyGLMKIDE Y64-p
PPP1R2 (rat) YHPADKDYGLMKIDE Y63
PPP1R2 (rabbit) YHPADKDYGLMKIDE Y63
S72-p
LMKIDEPstPyHSMM
Upstream
Downstream
2 0
Effects on Biological Processes:
  • cell motility, altered
Kinase, in vitro:
  • MARK3 (human)
Regulatory protein:
  • CCNYL1 (human)
  • WNT3A (human)
PPP1R2 (human) LMKIDEPstPyHSMM S72-p
PPP1R2 (mouse) LMKIDEPNtPYHNMI N73
PPP1R2 (rat) LMKIDEPDtPYHNMI D72
PPP1R2 (rabbit) LMKIDEPStPYHSMI S72
T73-p
MKIDEPstPyHSMMG
Upstream
Downstream
11 2
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
  • protein conformation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK5 (human)
  • GSK3B (human)
Putative in vivo kinases:
  • GSK3B (human)
Treatment
  • GSK-3_inhibitor_II
  • mimosine
  • nocodazole
  • seliciclib
PPP1R2 (human) MKIDEPstPyHSMMG T73-p
PPP1R2 (mouse) MKIDEPNtPYHNMIG T74-p
PPP1R2 (rat) MKIDEPDtPYHNMIG T73-p
PPP1R2 (rabbit) MKIDEPStPYHSMIG T73-p
Y75-p
IDEPstPyHSMMGDD
0 6
PPP1R2 (human) IDEPstPyHSMMGDD Y75-p
PPP1R2 (mouse) IDEPNtPYHNMIGDD Y76
PPP1R2 (rat) IDEPDtPYHNMIGDD Y75
PPP1R2 (rabbit) IDEPStPYHSMIGDD Y75
C86
MGDDEDACsDtEAtE
0 2
PPP1R2 (human) MGDDEDACsDtEAtE C86
PPP1R2 (mouse) IGDDEDAysDsEGNE Y87-p
PPP1R2 (rat) IGDDEDVCsDSEGNE C86
PPP1R2 (rabbit) IGDDDDAYsDTETTE Y86
S87-p
GDDEDACsDtEAtEA
Upstream
Downstream
4 17
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • CDK14 (human)
  • CK2A1 (human)
PPP1R2 (human) GDDEDACsDtEAtEA S87-p
PPP1R2 (mouse) GDDEDAysDsEGNEV S88-p
PPP1R2 (rat) GDDEDVCsDSEGNEV S87-p
PPP1R2 (rabbit) GDDDDAYsDTETTEA S87-p
T89-p
DEDACsDtEAtEAMA
0 6
PPP1R2 (human) DEDACsDtEAtEAMA T89-p
PPP1R2 (mouse) DEDAysDsEGNEVMt S90-p
PPP1R2 (rat) DEDVCsDSEGNEVMT S89
PPP1R2 (rabbit) DDDAYsDTETTEAMT T89
T92-p
ACsDtEAtEAMAPDI
0 1
PPP1R2 (human) ACsDtEAtEAMAPDI T92-p
PPP1R2 (mouse) AysDsEGNEVMtPDI N93
PPP1R2 (rat) VCsDSEGNEVMTPEI N92
PPP1R2 (rabbit) AYsDTETTEAMTPDT T92
A96
tEAtEAMAPDILARK
0 1
PPP1R2 (human) tEAtEAMAPDILARK A96
PPP1R2 (mouse) sEGNEVMtPDILAKK T97-p
PPP1R2 (rat) SEGNEVMTPEILAKK T96
PPP1R2 (rabbit) TETTEAMTPDTLAKK T96
Y114-p
AEGLEPKyRIQEQEs
0 4
PPP1R2 (human) AEGLEPKyRIQEQEs Y114-p
PPP1R2 (mouse) AEGSEPKYRTREQEs Y115
PPP1R2 (rat) AEGSEPKFRTREQEs F114
PPP1R2 (rabbit) AEGSEPKYRIREQEs Y114
S121-p
yRIQEQEssGEEDsD
Upstream
Downstream
4 97
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • CK2A1 (human)
Treatment
  • anti-CD3
  • ischemia
  • quinalizarin
PPP1R2 (human) yRIQEQEssGEEDsD S121-p
PPP1R2 (mouse) YRTREQEssGEEDND S122-p
PPP1R2 (rat) FRTREQEssGEEDND S121-p
PPP1R2 (rabbit) YRIREQEssGEEDSD S121-p
S122-p
RIQEQEssGEEDsDL
Upstream
Downstream
4 99
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • CK2A1 (human)
Treatment
  • anti-CD3
  • ischemia
  • quinalizarin
PPP1R2 (human) RIQEQEssGEEDsDL S122-p
PPP1R2 (mouse) RTREQEssGEEDNDL S123-p
PPP1R2 (rat) RTREQEssGEEDNDL S122-p
PPP1R2 (rabbit) RIREQEssGEEDSDL S122-p
S127-p
EssGEEDsDLsPEER
Upstream
1 8
Treatment
  • CXCL12
PPP1R2 (human) EssGEEDsDLsPEER S127-p
PPP1R2 (mouse) EssGEEDNDLsPEER N128
PPP1R2 (rat) EssGEEDNDLsPEER N127
PPP1R2 (rabbit) EssGEEDSDLSPEER S127
S130-p
GEEDsDLsPEEREKK
0 28
PPP1R2 (human) GEEDsDLsPEEREKK S130-p
PPP1R2 (mouse) GEEDNDLsPEEREKK S131-p
PPP1R2 (rat) GEEDNDLsPEEREKK S130-p
PPP1R2 (rabbit) GEEDSDLSPEEREKK S130
Y148-p
EMKRKLHyNEGLNIk
0 28
PPP1R2 (human) EMKRKLHyNEGLNIk Y148-p
PPP1R2 (mouse) EMKRKLHyNEGLNIK Y149-p
PPP1R2 (rat) EMKRKLHYNEGLNIk Y148
PPP1R2 (rabbit) EMKRKLHYNEGLNIK Y148
K155-ac
yNEGLNIkLARQLIS
0 2
PPP1R2 (human) yNEGLNIkLARQLIS K155-ac
PPP1R2 (mouse) yNEGLNIKLARQLIS K156
PPP1R2 (rat) YNEGLNIkLARQLIS K155-ac
PPP1R2 (rabbit) YNEGLNIKLARQLIS K155
K163
LARQLISKDLHDDDE
0 1
PPP1R2 (human) LARQLISKDLHDDDE K163
PPP1R2 (mouse) LARQLISKDLHDDDE K164
PPP1R2 (rat) LARQLISkDLHDDDE K163-ac
PPP1R2 (rabbit) LARQLISKDLHDDEE K163